title: Stopping HPVs dead in their tracts.
abstract: Vaccines are currently available to prevent infection of the genital tract and subsequent disease for some human papillomavirus (HPV) types, and attempts to develop broadly cross-reactive HPV vaccines are progressing. A recently developed murine model of cervicovaginal HPV infection examines the mechanisms by which antibodies prevent infection in vivo.
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle, WA, USA. jcarter@fhcrc.org
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Carter
authors.forename: Denise A
authors.initials: DA
authors.lastname: Galloway